Yuki Yamada - Concepedia

Author

Yuki Yamada

Also Known As

Y Mizumoto, Y YAMADA, Y Yamada, Y. Yamada, YOSHIHARU YAMADA, Yamada, Y., Yoshiaki Yamada, Yoshiharu Yamada, Yuki YAMADA, Yuki Yamada

298

Publications

3.5K

Citations

H-Index

188

Concepts

All Affiliations

NTT (Japan)Nara Medical University Kindai University Niigata University Kindai University Sakai Hospital

About

Yuki Yamada is an author at NTT (Japan) specializing in engineering, photonics, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	16	28	616
2	Medicine	15	23	737
3	Health Sciences	11	11	227
4	Public Health	3	3	59
5	Education	2	2	34

Yuki Yamada

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non–Small Cell Lung Cancer Cell Lines Tsutomu Iwasa, Isamu Okamoto, Minoru Suzuki, Clinical Cancer Research	2008	152
Frequent association of p53 gene mutation in invasive bladder cancer. Kiyohide Fujimoto, Yuki Yamada, Tadao Kakizoe, PubMed	1992	150
Analysis of risk factors for the development of gallstones after gastrectomy Takeshi Kobayashi, M Hisanaga, H Kanehiro, British journal of surgery	2005	104
Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status Yusaku Akashi, Isamu Okamoto, Tsutomu Iwasa, British Journal of Cancer Antitumor ActivityImmunologyImmunotherapyTumor BiologyHumanised Monoclonal Antibody	2008	101
Silica-based optical waveguide on terraced silicon substrate as hybrid integration platform Yuki Yamada, Akihiro Takagi, I. Ogawa, Electronics Letters PhotonicsWaveguidesOptical MaterialsEngineeringTerraced Silicon Substrate	1993	99
Sorafenib Inhibits Non–Small Cell Lung Cancer Cell Growth by Targeting B-RAF in <i>KRAS</i> Wild-Type Cells and C-RAF in <i>KRAS</i> Mutant Cells Ken Takezawa, Isamu Okamoto, Kimio Yonesaka, Cancer Research Tumor BiologyOncologyOncogenic AgentCell SignalingRna Interference	2009	92
Induction of a variety of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659----Glu659). Yoko Suda, Shinichi Aizawa, Yasuhide Furuta, The EMBO Journal Tumor BiologyClonal NatureLymphoid NeoplasiaMedicineCancer Cell Biology	1990	90
Application of planar lightwave circuit platformto hybrid integrated optical WDM transmitter/receiver module Yuki Yamada, S. Suzuki, K. Moriwaki, Electronics Letters	1995	86
Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase Takafumi Okabe, Isamu Okamoto, Sayaka Tsukioka, Molecular Cancer Therapeutics	2008	78
TAK-701, a Humanized Monoclonal Antibody to Hepatocyte Growth Factor, Reverses Gefitinib Resistance Induced by Tumor-Derived HGF in Non–Small Cell Lung Cancer with an <i>EGFR</i> Mutation Wataru Okamoto, Isamu Okamoto, Kaoru Tanaka, Molecular Cancer Therapeutics	2010	72

Page 1